Cadre Bioscience is developing a portfolio of new therapeutics for human diseases of high unmet medical need.

For more information, visit Cadre Bioscience or follow their updates on:


Cadre Bioscience Articles

In 2019, BioGenerator Invested $3.2 Million in 16 Bioscience Companies in St. Louis

BioGenerator’s New Strategies Address St. Louis’ Talent Shortage